PhRMA Appeals To Japanese Government To Abolish 14-Day Prescription Limit
This article was originally published in PharmAsia News
Executive Summary
PhRMA sees no need for the 14-day prescription limit of new drugs in Japan, according to the association’s vice president and Abbvie CEO Gary M. Weiner.